22 May 2013
Keywords: protein, therapeutics, immunoglobulin, ra, phase, ii, trial
Article | 22 December 1998
A Phase II trial of Protein Therapeutics' oral human immunoglobulin hasshown it has great potential for the treatment of severe ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.